AusBiotech is compiling a booklet of tributes and messages to Dr Anna Lavelle, in recognition of her outstanding tenure and contribution to AusBiotech and the biotechnology industry – and you are invited to contribute a comment.
Dr Lavelle will step down from the leadership on 1 September, after 11 years of excellent service to biotechnology and meritorious service to AusBiotech, which has seen her conferred a Life Membership of the organisation.
The booklet will serve as a fitting memento for the highly-respected leader who has been at the helm of AusBiotech for more than a decade, making an indelible mark on the success of AusBiotech and Australia’s life sciences industry.
The leadership changes at AusBiotech will take effect from 1 September 2016 and see Dr Lavelle’s tenure continue in the role of Principal Advisor to the Board. At the same time, current Chief Operating Officer, Mr Glenn Cross, will step into the role of CEO with Chief Industry Affairs Officer, Ms Lorraine Chiroiu, as the Deputy CEO.
Tributes and messages to Dr Anna Lavelle can be lodged with Communications and Media Officer, Kristen Goodgame at kgoodgame@ausbiotech.org by 25 August 2016 for inclusion.